Voting Rights and Capital
August 04 2010 - 12:19PM
UK Regulatory
TIDMHIK
RNS Number : 5588Q
Hikma Pharmaceuticals Plc
04 August 2010
Hikma Pharmaceuticals PLC - Voting Rights and Capital
LONDON, 4 August 2010 Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK)
notifies the market that as at 31 July 2010 its capital consists of 193,366,489
ordinary shares with voting rights. There are no shares held in treasury.
The above figure (193,366,489) may be used by shareholders as the denominator
for the calculations by which they will determine if they are required to notify
their interest in, or a change to their interest in, Hikma Pharmaceuticals PLC
under the FSA's Disclosure and Transparency Rules.
- ENDS -
Enquiries:
+---------------------------+------------------------------+
| Hikma Pharmaceuticals PLC | |
+---------------------------+------------------------------+
| Henry Knowles | +44 20 7399 2760 |
| Company Secretary | |
| | |
+---------------------------+------------------------------+
| | |
+---------------------------+------------------------------+
About Hikma
Hikma Pharmaceuticals PLC is a fast growing multinational group focused on
developing, manufacturing and marketing a broad range of both branded and
non-branded generic and in-licensed products. Hikma's operations are conducted
through three businesses: "Branded", "Injectables" and "Generics" based
principally in the Middle East and North Africa ("MENA") region, where it is a
market leader, the United States and Europe. In 2009, Hikma achieved revenues
of $637 million and profit attributable to shareholders of $78 million. For
news and other information, please visit www.hikma.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
TVRQZLFBBVFFBBK
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024